Invesco India Pharma and Healthcare Fund - Direct Plan - Growth
Benchmark: BSE Healthcare TRI · Riskometer: -
Invesco India Pharma and Healthcare Fund is a Sectoral mutual fund managed by Invesco Asset Management (India) Private Limited, benchmarked against BSE Healthcare TRI.
View full analysis on Punji.ai →
LEARN: Growth of ₹100 · NAV · CAGR
CHART
Invesco India Pharma and Healthcare Fund - growth of ₹100
Growth of ₹100 invested on 2026-09-30, not raw NAV - the standard way to compare fund performance regardless of NAV level. Daily resolution for the last 90 days, weekly up to 2 years, monthly beyond that.
NAV History - Last 30 Days(exact daily NAV)
| Date | NAV (₹) | 1D Change |
|---|---|---|
| 2026-10-28 | 9.5 | +0.05 (+0.5%) |
| 2026-10-27 | 9.45 | +0.33 (+3.6%) |
| 2026-10-26 | 9.12 | +0.17 (+1.9%) |
| 2026-10-25 | 8.95 | +0 (+0%) |
| 2026-10-23 | 8.95 | -0.02 (-0.2%) |
| 2026-10-22 | 8.97 | +0 (+0%) |
| 2026-10-21 | 8.97 | -0.03 (-0.3%) |
| 2026-10-20 | 9 | +0 (+0%) |
| 2026-10-19 | 9 | -0.07 (-0.8%) |
| 2026-10-18 | 9.07 | +0 (+0%) |
| 2026-10-16 | 9.07 | -0.07 (-0.8%) |
| 2026-10-15 | 9.14 | +0 (+0%) |
| 2026-10-14 | 9.14 | -0.11 (-1.2%) |
| 2026-10-13 | 9.25 | -0.04 (-0.4%) |
| 2026-10-12 | 9.29 | -0.09 (-1%) |
| 2026-10-11 | 9.38 | +0 (+0%) |
| 2026-10-09 | 9.38 | +0.14 (+1.5%) |
| 2026-10-08 | 9.24 | -0.22 (-2.3%) |
| 2026-10-07 | 9.46 | -0.01 (-0.1%) |
| 2026-10-06 | 9.47 | +0.06 (+0.6%) |
| 2026-10-05 | 9.41 | -0.16 (-1.7%) |
| 2026-10-04 | 9.57 | +0 (+0%) |
| 2026-10-01 | 9.57 | -0.02 (-0.2%) |
| 2026-09-30 | 9.59 | - |
Punji Fund Health Score - percentile-within-category. See methodology.
CATEGORY COMPARISON
Invesco India Pharma and Healthcare Fund returns
This fund is less than a year old, so there is not yet enough history to calculate rolling returns.
Invesco India Pharma and Healthcare Fund category rank vs peers
| Metric | Value | Rank | Category median |
|---|---|---|---|
| Total Expense Ratio | 0.59% | #1 of 20 (lower is better) | 1.08% |
Invesco India Pharma and Healthcare Fund risk metrics
This fund is less than three years old, so a three-year risk history does not exist yet.
Invesco India Pharma and Healthcare Fund holdings
Portfolio as of 2026-09-30
Hold multiple funds? See our Portfolio Overlap Tool to see if they actually hold different stocks.
CHART
Top sector holdings
Share of portfolio (% to NAV) in each of the top sectors.
TOP HOLDINGS
Funds similar to Invesco India Pharma and Healthcare Fund
Top funds in the same category, ranked by performance - not holdings overlap. Pick up to 2 to compare alongside this fund:
Invesco India Pharma and Healthcare Fund Punji analytics
CHART
Asset Allocation
As of Sep-2026
CHART
Market Cap Split
As of Sep-2026
Portfolio analytics as of Sep-2026.
Frequently asked questions
What is Invesco India Pharma and Healthcare Fund's expense ratio?
Invesco India Pharma and Healthcare Fund's direct-plan expense ratio is 0.59% per year - the annual fee the AMC deducts from the fund's assets to cover management and operating costs, already reflected in the NAV you see (it isn't billed separately). Direct plans skip the distributor commission built into Regular plans, which is why a direct-plan expense ratio is almost always lower than the same scheme's Regular-plan version. Over long holding periods, even a difference of a few basis points compounds into a meaningfully different final corpus, which is why expense ratio is one of the few fund attributes an investor can compare with total certainty before investing, unlike future returns.
How does Invesco India Pharma and Healthcare Fund's expense ratio compare to its category?
Invesco India Pharma and Healthcare Fund's expense ratio of 0.59% ranks #1 of 20 funds in the Sectoral Fund category (lower is better) - the category median is 1.08%. Expense ratio is deducted from the fund's assets every year regardless of performance, so a lower ratio is a real, certain cost advantage rather than a projection, unlike future returns.
How concentrated are Invesco India Pharma and Healthcare Fund's top holdings?
Invesco India Pharma and Healthcare Fund's single largest disclosed holding, Triparty Repo, accounts for 20.56% of NAV. Its top 5 holdings together make up 55.8% of the portfolio, and its top 10 disclosed holdings make up 91.1% - as of 2026-09-30. A higher concentration in the top few names means the fund's returns lean more heavily on those specific bets paying off, while a flatter spread means no single holding drives outcomes as much either way.
Who manages Invesco India Pharma and Healthcare Fund, and what category does it belong to?
Invesco India Pharma and Healthcare Fund is managed by Invesco Asset Management (India) Private Limited and is classified under the Sectoral Fund category, the SEBI-defined scheme categorization that groups funds by their investment mandate (market-cap focus, sector, or asset mix) so investors can compare like-for-like funds rather than across unrelated strategies. The AMC (asset management company) is the regulated entity legally responsible for the fund's operations, portfolio decisions, and disclosures, though day-to-day investment calls are made by a designated fund manager within the mandate set by the scheme's category and stated objective.
Data as of 2026-10-29. Source: AMFI disclosures via Punji. Not investment advice.